Predictors for extremely low serum infliximab trough concentration in patients with crohn's disease

被引：0
|
作者：
Mak, Lung-Yi [1 ]
Tong, Teresa [1 ]
Chen, Equal L. J. [1 ]
Ko, Michael [1 ]
To, Elvis [1 ]
Liu, Kevin S. H. [1 ]
Hung, Ivan F. N. [1 ]
Leung, Wai K. [1 ]
机构：
[1] Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2016年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1568
引用
收藏
页码：169 / 169
页数：1
相关论文
共 50 条
  • [1] Infliximab treatment decreases serum osteoprotegerin concentration in patients with Crohn's disease
    Miheller, Pal
    Muzes, Gyorgyi
    Racz, Karoly
    Blazovits, Anna
    Lakatos, Peter
    Herszenyi, Laszlo
    Tulassay, Zsolt
    GASTROENTEROLOGY, 2007, 132 (04) : A364 - A364
  • [2] Predictors of response to infliximab in patients with Crohn's disease
    Parsi, MA
    Achkar, JP
    Richardson, S
    Katz, J
    Hammel, JP
    Lashner, BA
    Brzezinski, A
    GASTROENTEROLOGY, 2002, 123 (03) : 707 - 713
  • [3] Evaluation of Infliximab Therapy in Children with Crohn's Disease Using Trough Levels Predictors
    Ohem, Jan
    Hradsky, Ondrej
    Zarubova, Kristyna
    Copova, Ivana
    Bukovska, Petra
    Prusa, Richard
    Malickova, Karin
    Bronsky, Jiri
    DIGESTIVE DISEASES, 2017, 36 (01) : 40 - 48
  • [4] Cytokine Profile at Diagnosis Affecting Trough Concentration of Infliximab in Pediatric Crohn's Disease
    Kwon, Yiyoung
    Kim, Eun-Sil
    Kim, Yoon-Zi
    Choe, Yon-Ho
    Kim, Mi-Jin
    BIOMEDICINES, 2022, 10 (10)
  • [5] Discussion on predictors of response to infliximab in patients with Crohn's disease
    Hommes, D
    GASTROENTEROLOGY, 2003, 124 (07) : 2002 - 2003
  • [6] Predictors of response to infliximab in patients with fistulizing Crohn's disease
    Luna-Chadid, M
    Calle, JLP
    Mendoza, JL
    Vera, MI
    Bermejo, AF
    Sánchez, F
    San Román, AL
    Froilán, C
    González-Lara, V
    García-Paredes, J
    Fernández-Blanco, I
    Abreu, L
    Casis, B
    Herruzo, JAS
    Gisbert, JP
    Maté-Jiménez, J
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2004, 96 (06) : 379 - 381
  • [7] Clinical correlations of infliximab trough levels and antibodies to infliximab in Korean patients with Crohn's disease
    Oh, E. H.
    Ko, D. -H.
    Seo, H.
    Chang, K.
    Kim, G. -U.
    Song, E. M.
    Seo, M.
    Lee, H. -S.
    Hwang, S. W.
    Yang, D. -H.
    Ye, B. D.
    Byeon, J. -S.
    Myung, S. -J.
    Yang, S. -K.
    Park, S. H.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S283 - S284
  • [8] Infliximab trough levels may predict sustained response to infliximab in patients with Crohn's disease
    Bortlik, Martin
    Duricova, Dana
    Malickova, Karin
    Machkova, Nadezda
    Bouzkova, Eva
    Hrdlicka, Ludek
    Komarek, Arnost
    Lukas, Milan
    JOURNAL OF CROHNS & COLITIS, 2013, 7 (09): : 736 - 743
  • [9] Correlation between Treatment Outcomes and Serum Vitamin D Levels As Well As Infliximab Trough Concentration among Chinese Patients with Crohn's Disease
    Song, Xiaomei
    Zhang, Huihui
    Wang, Hao
    Li, Zhongyue
    Zhou, Xiaoqin
    Guo, Hong
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2023, 2023
  • [10] Genetic predictors of long-term response and trough levels of infliximab in crohn's disease
    Salvador-Martin, Sara
    Lopez-Cauce, Beatriz
    Nunez, Olga
    Laserna-Mendieta, Emilio J.
    Garcia, Maria, I
    Lobato, Elena
    Abarca-Zabalia, Judith
    Sanjurjo-Saez, Maria
    Lucendo, Alfredo J.
    Marin-Jimenez, Ignacio
    Menchen, Luis A.
    Lopez-Fernandez, Luis A.
    PHARMACOLOGICAL RESEARCH, 2019, 149
12345